The FDA has approved Eucrisa (crisaborole) ointment for the treatment of mild to moderate eczema (atopic dermatitis) in patients aged 2 years and older.
A large, community-based randomized trial found that once-daily, full-body emollient use beginning in early infancy reduced the risk of developing atopic dermatitis by age 2. The protective effect was...